Biotech News

Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty

Pacira BioSciences (PCRX)Pacira BioSciences2026-06-25 13:46 ESTCompany update

Findings presented at ISPOR 2026 showed lower opioid consumption, reduced healthcare costs, and fewer opioid-related adverse events associated with EXPAREL use BRISBANE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to

Open original release

Related news

PCRXPacira BioSciences2026-06-25 13:46 EST

Pacira BioSciences Announces Stockholders Have Elected All Three of the Company's Director Nominees at Annual Meeting

PCRXPacira BioSciences2026-06-25 13:46 EST

Pacira BioSciences Reminds Stockholders to Vote the BLUE Proxy Card "FOR" the Election of the Company's Highly Qualified Nominees Ahead of its Annual Meeting

PCRXPacira BioSciences2026-06-25 13:46 EST

Pacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS' Recommendation to Vote "FOR" All of Pacira's Director Nominees

PCRXPacira BioSciences2026-06-25 13:46 EST

Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Pacira’s Director Nominees

PCRXPacira BioSciences2026-06-25 13:46 EST

Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company’s Strategic Direction and Highly Qualified Nominees

PCRXPacira BioSciences2026-06-25 13:46 EST

Pacira BioSciences Sets the Record Straight Regarding DOMA’s Misleading Statements About Pacira’s Intellectual Property Strategy

PCRXPacira BioSciences2026-06-25 13:46 EST

Pacira BioSciences Files Investor Presentation Highlighting Successful Execution of its Long-Term Strategy to Drive Value for All Stockholders

PCRXPacira BioSciences2026-06-25 13:46 EST

Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences

PCRXPacira BioSciences2026-06-25 13:46 EST

Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees

PCRXPacira BioSciences2026-06-25 13:46 EST

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

View all latest news

Pacira BioSciences

Pacira BioSciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

Recent company news

PCRXPacira BioSciences2026-06-26 08:21 EST

Pacira BioSciences Announces Stockholders Have Elected All Three of the Company's Director Nominees at Annual Meeting

PCRXPacira BioSciences2026-06-26 08:21 EST

Pacira BioSciences Reminds Stockholders to Vote the BLUE Proxy Card "FOR" the Election of the Company's Highly Qualified Nominees Ahead of its Annual Meeting

PCRXPacira BioSciences2026-06-26 08:21 EST

Pacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS' Recommendation to Vote "FOR" All of Pacira's Director Nominees

PCRXPacira BioSciences2026-06-26 08:21 EST

Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Pacira’s Director Nominees

PCRXPacira BioSciences2026-06-26 08:21 EST

Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company’s Strategic Direction and Highly Qualified Nominees

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States